CASP9 Monoclonal Antibody
Product Specifications
Background
Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. Proteolytically cleaves poly (ADP-ribose) polymerase (PARP) .Isoform 2 lacks activity is an dominant-negative inhibitor of caspase-9.
Abbreviation
Caspase 9
UniProt
P55211
Host
Mouse
Reactivity
Human
Immunogen
Synthetic Peptide
Target
APAF-3; APAF3; Apoptosis related cysteine peptidase; Apoptotic protease Mch-6; Apoptotic protease-activating factor 3; CASP-9; CASP9; CASP9; Caspase 9 apoptosis related cysteine peptidase; Caspase 9 Dominant Negative; Caspase 9c; Caspase-9; Caspase-9 subunit p10; ICE LAP6; ICE like apoptotic protease 6; ICE-LAP6; ICE-like apoptotic protease 6; MCH6; PPP1R56; protein phosphatase 1; regulatory subunit 56; RNCASP9
Clonality
Monoclonal
Clone
Clone:3I3
Conjugation
Unconjugated
Applications
WB; IHC-p; IF; IP
Field of Research
Cancer; Cell Biology; Metabolism
Purification
Protein A purification
Concentration
1 mg/mL
Dilution
WB 1:500-1:2000; IHC 1:50-300; IF 1:50-1:200; IP 1:100-1:300
Buffer
PBS with 0.02% sodium azide and 50% glycerol pH 7.4.
Shipping Conditions
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight
46kDa
Observed Molecular Weight
47-51kDa
Citation 01
https://pubs.rsc.org/en/content/articlelanding/2021/fo/d1fo01547h
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP721877M 100 µg
AQP5 Human Recombinant Protein, Membrane Nanoparticle
Sign In for Pricing
View Details 
BNC680769-100 1x 100 µL
P27 / KIP1 (KIP1/769), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY422933 100 µg
Meis homeobox 3 (MEIS3) (NM_001009813) Human Over-expression Lysate
Sign In for Pricing
View Details 